KBC Group is a financial services provider headquartered in Brussels, Belgium, specializing in banking and insurance solutions tailored for retail clients, private banking, small and medium-sized enterprises, and mid-cap clients. The company offers a comprehensive range of products, including loans, deposits, asset management, life and non-life insurance, as well as cash management, payments, trade finance, leasing, and corporate finance services. In addition to these offerings, KBC Private Equity, the investment arm of KBC Group, focuses on providing development capital and financing buy-outs for medium-sized companies in Belgium and Central and Eastern Europe. With an experienced team of 28 professionals and over 60 active investments valued at more than EUR 400 million, KBC Private Equity aims to establish itself as a leading private equity provider in its home markets, actively participating in strategic decision-making and supporting management teams to drive growth.
ClimateCamp is a developer of a greenhouse gas accounting platform aimed at de-carbonizing supply chains. The platform provides detailed information on carbon emissions throughout the supply chain, enabling companies to gain a comprehensive view of their carbon footprint. By facilitating collaboration among key stakeholders, ClimateCamp offers up-to-date insights into emissions, allowing businesses to efficiently target their reduction efforts.
MICLEDI Microdisplays BV specializes in designing and manufacturing micro light-emitting diode (microLED) display chips tailored for augmented reality (AR) glasses. Based in Leuven, Belgium, the company operates as a fabless developer, focusing on advanced technology that integrates III/V materials processing, 3D integration, and 300mm silicon-based processing. MICLEDI's proprietary application-specific integrated circuit (ASIC) enables the production of compact, monolithic AR displays that deliver high image quality and enhanced power efficiency. By providing microLED display modules on wafers, MICLEDI serves the semiconductor industry, contributing to the advancement of AR technology.
Discai empowers financial service providers to fully focus on their core business. Setting new standards with innovative AI solutions, Discai ensures you of worry-free smart fin tools. As a full subsidiary of KBC Group, Discai commercialises KBC’s in-house developed innovative AI applications. Gradually releasing these apps onto the market, Discai makes this technology accessible for other players in the financial world in a Bank/Insurance-as-a-Service model.
Settle is a real estate application that aims to enhance the home renovation process by providing clients with tools to optimize their budgets and make informed decisions. The platform supports users during the pre-purchase phase by offering insights on price tags, renovation estimates, and local vacancies, facilitating a smoother home buying experience. Additionally, Settle fosters collaboration by connecting digital files to payment, streamlining exchanges and providing built-in trust. As the professional community increasingly shifts to digital and remote collaboration, Settle addresses the shortcomings of traditional methods by offering a seamless and efficient solution for transferring digital work. The company's mission is to empower users to maximize their resources and improve transparency in the renovation process.
Unbox has developed a proprietary technology to imbue virtually anything with a memory, a conscience, and a forward-looking vision. This transformative capability embraces a diverse range of assets, from financial resources to tangible products. Emphasising privacy and security, the Unbox technology facilitates closed loops, allowing the parties to an exchange to exercise control, distribution, and registration of any (un)fungible value. Whether it is traditional currency or local community currencies through the Unbox Community Issuance software suite, or high-value assets like diamonds or semi-conductors, and even low-value items such as plastic bottles or toys using the Unbox State of Product software suite, Unbox's platform offers unparalleled versatility.
Raiffeisenbank Bulgaria is a banking institution that offers a range of financial products and services tailored to both individual and corporate clients. It serves various customer segments, including individuals, micro and small enterprises, and larger institutional clients. The bank's offerings encompass retail and corporate banking services, investment solutions, mortgage lending, and credit and debit card services. Additionally, it provides savings accounts, loans, and insurance products, aiming to meet the diverse financial needs of its clientele.
Guud Woman is the destination for women who want to improve their menstrual health. We're a platform that vertically integrates support and natural supplements to offer the help that women deserve.
NN Group-Pension and life insurance business
Acquisition in 2021
NN Group-Pension and life insurance businesses offer Life Insurance, Mandatory Pensions, and Voluntary Pensions.
Stellar Labs specializes in transforming workplace learning through its innovative AI-driven platform, which integrates neuroscience-based methodologies to enhance professional development. The company's offerings include a variety of open and customizable learning programs that blend digital training with interactive workshops, peer collaboration, and practical assignments. This approach aims to address the skills gap in the technology sector by ensuring efficient knowledge transfer and real-world application. Key features of the platform include rapid design and delivery of learning experiences, evidence-based training for improved knowledge retention, and adaptive learning paths that personalize education for each individual. Furthermore, Stellar Labs emphasizes measurable outcomes, providing insights into performance improvements and productivity gains within organizations. By fostering a dynamic learning culture, Stellar Labs equips teams with essential skills for the future, ultimately driving enhanced performance and productivity.
Wizata is make sense of your data and discover unique solutions and unexploited opportunities. Wizata proposes vertical solutions answering to your specific sector challenges. As main domains of expertize, Wizata counts today the Manufacturing (Industry 4.0), Insurance, Energy, Healthcare sectors and e-commerce for predictive management and process optimization. By embedding themselves in your business and synergising with your teams, WIZATA’s data scientists uncover hidden gems within your data, whether internal or external to your organisation. Every profile is an exception, that’s why WIZATA offers an advanced collaboration model with people who are real experts in data science. Unique profiles for unique services.
ArtiQ is an innovative spin-off from the University of Leuven, founded in early 2019 by a team with extensive experience in respiratory medicine, medical devices, and artificial intelligence. The company focuses on developing AI-backed software to support medical professionals in diagnosing, treating, and monitoring patients with lung diseases. By automating the interpretation of pulmonary function tests, ArtiQ's technology enhances the accuracy and efficiency of the diagnostic process, facilitating the early detection of disease patterns. This approach not only aids healthcare practitioners in making informed decisions but also aims to improve the overall environment for lung disease diagnostics, ultimately benefiting patients and the healthcare system. ArtiQ aspires to be a trusted partner for medical practitioners in addressing respiratory issues.
Together with thousands of other merchants, you are the beating heart of your neighbourhood. From that hot cup of coffee while your customer waits, to that little extra for that loyal customer having a tough day. Every single day, you go that extra mile for your customers. We combined all of your extra efforts into one single app. With Joyn, your customers enjoy unique advantages, save for cool rewards and keep coming back to you. Joyn provides you the tools to help you grow your business.
United Bulgarian Bank offers a wide range of banking products and services tailored for individual, microbusiness, and corporate clients in Bulgaria. The bank provides deposit options such as savings accounts, current accounts, and online deposits. Its loan offerings include consumer loans, mortgage loans, and various credit lines, along with specialized loans for agriculture and those under European programs. Additionally, United Bulgarian Bank issues debit and credit cards and provides services in insurance, investment banking, mobile banking, and trade finance. Through these services, the bank aims to deliver personalized banking solutions to its diverse clientele.
UBB Interlease is a Bulgarian lease company part of the Belgian banking and insurance group KBC. The activities of Interlease are targeted towards increasing the competitiveness and improving the market positions of the Bulgarian enterprises both domestically and abroad. Interlease finances the acquisition of high-quality equipment, transportation vehicles, cars and office equipment. The company provides its customers with professional service after delivery of the asset, based on effective internet and mobile technologies.
Go Vocal is a digital community engagement platform that facilitates interaction between local governments and their communities. It provides a centralized tool for conducting surveys, ideation, participatory budgeting, deliberation, and information sharing. By employing artificial intelligence and natural language processing, Go Vocal transforms unstructured citizen input into actionable insights, allowing governments to analyze and moderate feedback effectively. The platform also generates automated reports that offer valuable insights for decision-making. Ultimately, Go Vocal aims to enhance the inclusiveness and responsiveness of governmental decisions by enabling efficient management of citizen ideas and real-time data analysis.
VB Leasing SK is a universal leasing company operating a network of 11 branches, 90 dealers and agents. The total workforce of the company is approximately 90 full-time employees.
Pronota NV is a Belgian company specializing in the development and commercialization of innovative diagnostics aimed at the early detection of life-threatening conditions, such as heart failure, pre-eclampsia, and sepsis. The company utilizes a proprietary protein biomarker diagnostics platform that is non-invasive and validated, focusing on enhancing patient care and addressing unmet medical needs. Founded in 2004 and based in Zwijnaarde, Belgium, Pronota has garnered support from prominent investors and a network of key opinion leaders in the medical field. The firm was previously known as Peakadilly NV before rebranding in 2006.
BIC specialises in assisting international investors in acquiring businesses, as well as local companies in attracting strategic partners, and can look back on a number of successfully completed M&A transactions. From one region to another, the value of the deals it works on varies between 10 and 200 million euros. Its business portfolio is spread evenly across the various regions in which the company operates. BIC targets midcaps and is a strong player in the financial services, consumer goods, retail, distribution and selected industrial sectors.
Biocartis SA is a molecular diagnostics company based in Lausanne, Switzerland, focused on developing a technology platform for the multiplexed detection of bio-analytes. Established in 2007, Biocartis integrates molecular and immunodiagnostics through its proprietary micro-technology platform. The company offers a range of diagnostic solutions, including the Idylla molecular diagnostic system, which serves oncology and infectious disease applications. Its product portfolio features assays for various mutations, such as EGFR, BRAF, and NRAS, as well as a respiratory panel. These products are designed to enhance clinical practice by facilitating the detection, quantification, and monitoring of bio-molecules associated with disease risk factors and treatment decisions. Biocartis primarily generates revenue through the sale of its diagnostic products.
Argenx is a global immunology company based in the Netherlands, dedicated to enhancing the lives of individuals affected by severe autoimmune diseases and cancer. The company employs advanced antibody engineering technology to develop treatments for rare autoimmune conditions. Its notable product, Vyvgart (efgartigimod), received initial approval in the United States in December 2021 for the treatment of generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022. Through its innovative approaches, Argenx aims to address unmet medical needs in the field of immunology.
CymaBay Therapeutics is a clinical-stage biopharmaceutical company located in the San Francisco Bay Area focused on the development and commercialization of proprietary new medicines for important human diseases. We are committed to developing breakthrough medicines that improve the lives of patients and their families. CymaBay was seeded with the assets from an earlier metabolic disease company in which more than $120M was invested to produce a robust pipeline. Arhalofenate is a novel oral small molecule being developed to treat the approximately 1 million gout patients that flare three or more times per year. Gout flares are painful inflammatory episodes caused by crystals of monosodium urate (MSU) that result from excess serum uric acid (sUA). In three Phase 2 studies in gout patients arhalofenate was shown to reduce the incidence and duration of flares while simultaneously lowering sUA. If confirmed in additional clinical studies, arhalofenate’s dual acting profile would be unique since all other urate lowering therapies paradoxically increase flares as they lower sUA over the first 6 to 12 months of treatment. Increased flares lead many patients to stop or avoid treatment leading to progression of disease with pain and suffering, erosion of joint structure and functionality, lost time from work, and increased healthcare costs.
Argenx is a global immunology company based in the Netherlands, dedicated to enhancing the lives of individuals affected by severe autoimmune diseases and cancer. The company employs advanced antibody engineering technology to develop treatments for rare autoimmune conditions. Its notable product, Vyvgart (efgartigimod), received initial approval in the United States in December 2021 for the treatment of generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022. Through its innovative approaches, Argenx aims to address unmet medical needs in the field of immunology.
Pronota NV is a Belgian company specializing in the development and commercialization of innovative diagnostics aimed at the early detection of life-threatening conditions, such as heart failure, pre-eclampsia, and sepsis. The company utilizes a proprietary protein biomarker diagnostics platform that is non-invasive and validated, focusing on enhancing patient care and addressing unmet medical needs. Founded in 2004 and based in Zwijnaarde, Belgium, Pronota has garnered support from prominent investors and a network of key opinion leaders in the medical field. The firm was previously known as Peakadilly NV before rebranding in 2006.
Aristo Music NV develops selection and distribution techniques and technologies for digital music and provides music related services. The company also develops various Internet applications, which include a Web radio that consists of a musical database. It serves catering, retail, business, leisure, and government markets. The company is based in Heverlee, Belgium.
Okapi Sciences NV is a Belgium-based company focused on developing antiviral therapeutics for pets and livestock. It operates a proprietary platform dedicated to creating innovative treatments for significant viral diseases, with five candidates currently in clinical or development stages. The company specializes in addressing viral infections affecting pets, particularly through its work on feline herpes and feline immunodeficiency virus. Okapi Sciences is committed to advancing its pipeline of antiviral drugs while fostering strong relationships with academic institutions to enhance its research capabilities and technological advancements in veterinary medicine.
Istrobanka is a provider of retail and wholesale banking products and services for corporate and individual customers in Slovakia. The company offers deposit products, savings and investment accounts, loans, corporate finance, insurance products, payment cards, mutual funds, and mortgage loans.
Senzal is a privately held company that specializes in providing brokerage services. It operates as a security brokerage firm, facilitating the buying and selling of financial securities for its clients. By focusing on delivering tailored brokerage solutions, Senzal aims to meet the diverse needs of investors in the financial market. The company is dedicated to offering a reliable platform for transactions, ensuring a seamless experience for its users.
Ceres is a non-profit organization focused on promoting sustainability leadership among businesses and investors. Based in Boston, Massachusetts, it mobilizes a diverse network of stakeholders, including companies and public interest groups, to enhance the adoption of sustainable practices that contribute to a healthier economy. Ceres conducts research on various aspects of business sustainability, examining trends and responses within sectors such as insurance, banking, and electric utilities, particularly concerning climate change and emissions. The organization also emphasizes the importance of climate risk disclosure and fuel economy standards in its efforts to advocate for a more sustainable future.
Hipobroker is a financial services provider operating in Serbia and Montenegro, specializing in brokerage services. The company facilitates the buying and selling of shares in the private market, offering valuable information to support security portfolios. By focusing on these financial services, Hipobroker aims to assist clients in navigating investment opportunities within the region.
CymaBay Therapeutics is a clinical-stage biopharmaceutical company located in the San Francisco Bay Area focused on the development and commercialization of proprietary new medicines for important human diseases. We are committed to developing breakthrough medicines that improve the lives of patients and their families. CymaBay was seeded with the assets from an earlier metabolic disease company in which more than $120M was invested to produce a robust pipeline. Arhalofenate is a novel oral small molecule being developed to treat the approximately 1 million gout patients that flare three or more times per year. Gout flares are painful inflammatory episodes caused by crystals of monosodium urate (MSU) that result from excess serum uric acid (sUA). In three Phase 2 studies in gout patients arhalofenate was shown to reduce the incidence and duration of flares while simultaneously lowering sUA. If confirmed in additional clinical studies, arhalofenate’s dual acting profile would be unique since all other urate lowering therapies paradoxically increase flares as they lower sUA over the first 6 to 12 months of treatment. Increased flares lead many patients to stop or avoid treatment leading to progression of disease with pain and suffering, erosion of joint structure and functionality, lost time from work, and increased healthcare costs.
Romstal Leasing IFN is the largest independent leasing company in Romania, specializing in a range of leasing services for both personal and commercial vehicles. As of the end of 2006, the company held a 4.20% share of the Romanian leasing market, positioning it as a significant player in the sector. Its primary focus is on car leasing, which accounts for 43.30% of its financing activities. In addition to vehicle leasing, Romstal Leasing also offers leasing solutions for delivery vans, lorries, machinery, equipment, and real estate, catering to diverse customer needs across various industries.
KBC Equitas is a privately held company that operates a stock exchange and offers online brokerage services. It provides an online trading system that allows clients to trade various financial instruments, including investment funds, shares, equities, certificates, exchange-traded funds, treasury bills, and futures. Through its platform, KBC Equitas aims to facilitate wealth preservation and enrichment for its clients.
Movetis NV, a pharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of diseases in the gastrointestinal (GI) area. Its products address GI disorders, such as severe chronic constipation, ascites, paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. The company's lead product, Resolor, is used for the symptomatic treatment of chronic constipation in women. Resolor is also tested for chronic constipation in males and children, as well as opioid-induced constipation and post operative ileus. Its products also include M0002, which is in Phase II trials to treat ascites, an accumulation of fluid caused by liver malfunction; and M0003 that is entering Phase II development for symptomatic treatment of heartburn and regurgitation in patient's refractory to PPIs, and pediatric reflux. In addition, the company also has two prioritized compounds out of its preclinical portfolio, M0014 and M0012, and two compound libraries. It has partnership agreements with the universities of Ghent, Leuven, and Rotterdam. The company was founded in 2006 and is headquartered in Turnhout, Belgium.
Banco Urquijo specializes in advising and managing legal entities, such as insurance companies, mutual companies, provident societies, cooperatives, and trusts that administer third party assets.
Ablynx is a biopharmaceutical company focused on the discovery and development of Nanobodies®, a unique class of therapeutic proteins derived from single-domain antibody fragments. These innovative proteins are designed to address a variety of serious human diseases, including inflammation, hematology, oncology, and pulmonary conditions. Currently, Ablynx has around 25 projects in its pipeline, with five Nanobodies in clinical development. By combining the advantages of traditional antibodies and small chemical molecules, Ablynx aims to provide new therapeutic options that can significantly improve patient care and outcomes.
Pronota NV is a Belgian company specializing in the development and commercialization of innovative diagnostics aimed at the early detection of life-threatening conditions, such as heart failure, pre-eclampsia, and sepsis. The company utilizes a proprietary protein biomarker diagnostics platform that is non-invasive and validated, focusing on enhancing patient care and addressing unmet medical needs. Founded in 2004 and based in Zwijnaarde, Belgium, Pronota has garnered support from prominent investors and a network of key opinion leaders in the medical field. The firm was previously known as Peakadilly NV before rebranding in 2006.
K&H Bank is a banking institution based in Budapest, Hungary, offering a wide range of financial services. Established in 1987, it operates as a wholly owned subsidiary of KBC Bank. The bank serves both retail and corporate clients, providing services such as lending, digital banking, insurance, wealth management, advisory, and transaction services. Additionally, K&H Bank specializes in corporate finance, agricultural loans, leasing, and funding for local governments, positioning itself as a comprehensive provider of financial solutions in the region.
HSBC Dewaay SA is a privately held company offers private banking and trustee services. It services include cash management, discretionary portfolio management, and patrimonial advisory services.
Effectenbank Stroeve N.V.
Acquisition in 2005
Effectenbank Stroeve N.V. is a privately held company offers capital management, stockbroking, and investment advisory services.
Aurel Leven
Acquisition in 2005
Aurel Leven Gestion, an independent asset management company, old, which manages funds on behalf of private clients and institutional investors. Aurel Leven Gestion, of February 2005, Aurel Leven Gestion was acquired by KBL France Gestion.
Aballea Finance SA is a privately held company specializing in wealth management and real estate management. The firm offers a range of financial advisory services, including real estate consulting, tax assistance, investment management, and financial reporting. By focusing on these areas, Aballea Finance aims to provide comprehensive support to its clients in managing their financial and real estate needs effectively.
Almanij NV
Acquisition in 2005
Almanij NV engages in banking, insurance, and investment activities; and the provision of specialized financial services.
CymaBay Therapeutics is a clinical-stage biopharmaceutical company located in the San Francisco Bay Area focused on the development and commercialization of proprietary new medicines for important human diseases. We are committed to developing breakthrough medicines that improve the lives of patients and their families. CymaBay was seeded with the assets from an earlier metabolic disease company in which more than $120M was invested to produce a robust pipeline. Arhalofenate is a novel oral small molecule being developed to treat the approximately 1 million gout patients that flare three or more times per year. Gout flares are painful inflammatory episodes caused by crystals of monosodium urate (MSU) that result from excess serum uric acid (sUA). In three Phase 2 studies in gout patients arhalofenate was shown to reduce the incidence and duration of flares while simultaneously lowering sUA. If confirmed in additional clinical studies, arhalofenate’s dual acting profile would be unique since all other urate lowering therapies paradoxically increase flares as they lower sUA over the first 6 to 12 months of treatment. Increased flares lead many patients to stop or avoid treatment leading to progression of disease with pain and suffering, erosion of joint structure and functionality, lost time from work, and increased healthcare costs.
WARTA S.A., established in 1920, is one of the largest and oldest insurance companies in Poland, recognized for setting standards in the country's insurance market. Headquartered in Warsaw, the company operates as a reinsurance broker and provides a diverse range of insurance products. Its offerings include motor, property, personal, financial, and third-party liability insurance, catering to various customer needs and contributing to the overall stability of the Polish insurance sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.